Pancreatic Adenocarcinoma with Venous Involvement: Is Up-Front Synchronous Portal-Superior Mesenteric Vein Resection Still Justified? A Survey of the Association Fran‡aise de Chirurgie

被引:82
作者
Delpero, Jean Robert [1 ]
Boher, Jean Marie [2 ]
Sauvanet, Alain [3 ]
Le Treut, Yves Patrice [4 ]
Sa-Cunha, Antonio [5 ]
Mabrut, Jean Yves [6 ]
Chiche, Laurence [7 ]
Turrini, Olivier [1 ]
Bachellier, Philippe [8 ]
Paye, Francois [9 ]
机构
[1] Univ Mediterrane, Inst Paoli Calmettes, Dept Surg Oncol, Marseille, France
[2] Univ Mediterrane, Inst Paoli Calmettes, Dept Biostat, Marseille, France
[3] Univ Paris 07, Hop Beaujon, Dept Surg, Clichy, France
[4] Univ Mediterrane, Hop Concept, Dept Surg, Marseille, France
[5] Univ Paris Sud, Hop Paul Brousse, Dept Surg, Villejuif, France
[6] Univ Lyon 1, Hop Croix Rousse, Dept Surg, F-69365 Lyon, France
[7] Univ Segalen, Hop Haut Leveque, Dept Surg, Bordeaux, France
[8] Univ Strasbourg, Hop Hautepierre, Dept Surg, Strasbourg, France
[9] Univ Paris 06, Hop St Antoine, Dept Surg, Paris, France
关键词
LONG-TERM SURVIVAL; VASCULAR RESECTION; ADJUVANT CHEMOTHERAPY; DUCTAL ADENOCARCINOMA; SURGICAL COMPLICATIONS; POSTOPERATIVE OUTCOMES; CANCER SURGERY; PANCREATICODUODENECTOMY; GEMCITABINE; THERAPY;
D O I
10.1245/s10434-014-4304-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Venous resection (VR) during pancreatectomy has been reported to neither increase mortality nor morbidity and to provide similar survival outcomes in same stage tumors. However, controversy remains regarding the indications for up-front surgery according to the degree of venous involvement. From 2004 to 2009, 1,399 patients included in a French multicenter survey underwent pancreaticoduodenectomy or total pancreatectomy for pancreatic adenocarcinoma, either without VR (997 standard resections [SR]) or with VR (402 patients; 29 %). Postoperative and long-term outcomes were compared in both groups. VR was associated with the following factors: larger tumors (p < 0.001), poorly differentiated tumors (p = 0.004), higher numbers of positive lymph nodes (p = 0.042), and positive resection margins (R1; p < 0.001). Overall, VR increased neither postoperative morbidity nor postoperative mortality (5 vs. 3 % in SR patients; p = 0.16). The median and 3-year survival rates in VR patients versus SR patients were 21 months and 31 % vs. 29 months and 44 %, respectively (p = 0.0002). In the entire cohort, multivariate analysis identified VR as a significant poor prognostic factor for long-term survival (hazard ratio [HR] 1.75, 95 % confidence interval [CI] 1.28-2.40; p = 0.0005). In the VR patients, lymph node ratio, whatever the cutoff (< 0.3: p = 0.093; a parts per thousand yen0.3: p = 0.0098), R1 resection (p = 0.010), and segmental resection (p = 0.016) were independent risk factors; neoadjuvant treatment (HR 0.52, 95 % CI 0.29-0.94; p = 0.031) and adjuvant treatment (HR 0.55, 95 % CI 0.35-0.85; p = 0.006) were significantly associated with improved long-term survival. Long-term survival after pancreatectomy was significantly altered when up-front VR was performed. Neoadjuvant treatment may be a better strategy than up-front resection in patients with preoperative suspicion of venous involvement.
引用
收藏
页码:1874 / 1883
页数:10
相关论文
共 71 条
[1]   The Cost-Effectiveness of Neoadjuvant Chemoradiation is Superior to a Surgery-First Approach in the Treatment of Pancreatic Head Adenocarcinoma [J].
Abbott, Daniel E. ;
Tzeng, Ching-Wei David ;
Merkow, Ryan P. ;
Cantor, Scott B. ;
Chang, George J. ;
Katz, Matthew Harold ;
Bentrem, David J. ;
Bilimoria, Karl Y. ;
Crane, Christopher H. ;
Varadhachary, Gauri R. ;
Abbruzzese, James L. ;
Wolff, Robert A. ;
Lee, Jeffrey E. ;
Evans, Douglas B. ;
Fleming, Jason B. .
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 :S500-S508
[2]   Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement [J].
Abrams, Ross A. ;
Lowy, Andrew M. ;
O'Reilly, Eileen M. ;
Wolff, Robert A. ;
Picozzi, Vincent J. ;
Pisters, Peter W. T. .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (07) :1751-1756
[3]   Neoadjuvant/Preoperative Gemcitabine for Patients with Localized Pancreatic Cancer: A Meta-analysis of Prospective Studies [J].
Andriulli, Angelo ;
Festa, Virginia ;
Botteri, Edoardo ;
Valvano, Maria R. ;
Koch, Maurizio ;
Bassi, Claudio ;
Maisonneuve, Patrick ;
Di Sebastiano, Pierluigi .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (05) :1644-1662
[4]  
[Anonymous], ANN SURG IN PRESS
[5]  
[Anonymous], GLOB 2012 EST CANC I
[6]   Pancreatic head resectable adenocarcinoma: preoperative chemoradiation improves local control but does not affect survival [J].
Barbier, Louise ;
Turrini, Olivier ;
Gregoire, Emilie ;
Viret, Frederic ;
Le Treut, Yves-Patrice ;
Delpero, Jean-Robert .
HPB, 2011, 13 (01) :64-69
[7]   National failure to operate on early stage pancreatic cancer [J].
Bilimoria, Karl Y. ;
Bentrem, David J. ;
Ko, Clifford Y. ;
Stewart, Andrew K. ;
Winchester, David P. ;
Talamonti, Mark S. .
ANNALS OF SURGERY, 2007, 246 (02) :173-180
[8]   Hospital volume and surgical mortality in the United States. [J].
Birkmeyer, JD ;
Siewers, AE ;
Finlayson, EVA ;
Stukel, TA ;
Lucas, FL ;
Batista, I ;
Welch, HG ;
Wennberg, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15) :1128-1137
[9]   Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS) [J].
Bockhorn, Maximilian ;
Uzunoglu, Faik G. ;
Adham, Mustapha ;
Imrie, Clem ;
Milicevic, Miroslav ;
Sandberg, Aken A. ;
Asbun, Horacio J. ;
Bassi, Claudio ;
Buechler, Markus ;
Charnley, Richard M. ;
Conlon, Kevin ;
Cruz, Laureano Fernandez ;
Dervenis, Christos ;
Fingerhutt, Abe ;
Friess, Helmut ;
Gouma, Dirk J. ;
Hartwig, Werner ;
Lillemoe, Keith D. ;
Montorsi, Marco ;
Neoptolemos, John P. ;
Shrikhande, Shailesh V. ;
Takaori, Kyoichi ;
Traverso, William ;
Vashist, Yogesh K. ;
Vollmer, Charles ;
Yeo, Charles J. ;
Izbicki, Jakob R. .
SURGERY, 2014, 155 (06) :977-988
[10]   R0 in Pancreatic Cancer Surgery Surgery, Pathology, Biology, or Definition Matters? [J].
Buechler, Markus W. ;
Werner, Jens ;
Weitz, Juergen .
ANNALS OF SURGERY, 2010, 251 (06) :1011-1012